R&D Lobaratory Services

SHARE

Gencurix R&D Center is performing ceaseless research activities to developing the ‘multiplex assay’ which is core technology for economy in expenditures, time and samples. We have accumulated research capabilities and experiences of entire development process of molecular diagnostic products.

Most popular related searches

chemotherapy drug

biomarker discovery

cancer diagnosis

molecular diagnostic

biomarker development

Early diagnostics : Measures that can be taken to diagnose cancer as early as possible, when the disease is easiest to treat.
Prognostic Diagnosis : After surgery, predict survival rate and chemotherapy benefit
Companion Diagnosis : Classify patients who respond to targeted chemotherapy drugs

Biomarker discovery and commercialization
Development of ‘gene detection’ and‘multiplex assay’ based on various PCR technologies
Development of algorithm
Development of analysis software for result interpretation